Publicación:
Activación y determinación de parámetros cinéticos de la Plasmina Humana y Ovis aries

Vista sencilla de ítem
dc.contributor.authorCañas, Omairaspa
dc.contributor.authorQuijano, Alfonsospa
dc.contributor.authorArbeláez, Fernandospa
dc.date.accessioned2011-01-01 00:00:00
dc.date.accessioned2022-07-01T20:58:54Z
dc.date.available2011-01-01 00:00:00
dc.date.available2022-07-01T20:58:54Z
dc.date.issued2010-01-01
dc.format.mimetypeapplication/pdfspa
dc.identifier.doi10.21897/rmvz.295
dc.identifier.eissn1909-0544
dc.identifier.issn0122-0268
dc.identifier.urihttps://repositorio.unicordoba.edu.co/handle/ucordoba/5516
dc.identifier.urlhttps://doi.org/10.21897/rmvz.295
dc.language.isospaspa
dc.publisherUniversidad de Córdobaspa
dc.relation.bitstreamhttps://revistamvz.unicordoba.edu.co/article/download/295/363
dc.relation.citationeditionNúm. 1 , Año 2011 : Revista MVZ Córdoba Volumen 16(1) Enero-Abril 2011spa
dc.relation.citationissue1spa
dc.relation.citationvolume16spa
dc.relation.ispartofjournalRevista MVZ Córdobaspa
dc.relation.referencesKleinschnitz C, Stoll M, Bendszus K, Schuh H, Pauer P, Burfeind C et al. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis. J Exp Med 2006; 203:513–518. http://dx.doi.org/10.1084/jem.20052458spa
dc.relation.referencesMackman N. Role of tissue factor in hemostasis thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 2004; 24:1015–1022. http://dx.doi.org/10.1161/01.ATV.0000130465.23430.74spa
dc.relation.referencesWhelihan MF, Orfeo T, Gissel MT, Mann KG. Coagulation procofactor activation by factor XIa. J Thromb Haemost 2010; 7:1532–1539. http://dx.doi.org/10.1111/j.1538-7836.2010.03899.xspa
dc.relation.referencesKolodziejczyk J, Wachowicz B. Dysfunction of fibrinolysis as a risk factor of thrombosis. Pol Merkur Lekarski 2009; 160:341–5.spa
dc.relation.referencesZhang L, Seiffert D, Fowler BJ, Jenkins GR, Thinnes TC, Loskutoff DJ, Parmer RJ, Miles LA. Plasminogen has a broad extrahepatic distributions. Thromb Haemost 2002; 87:493–501.spa
dc.relation.referencesKouemo S, McMillan E, Doctor V. Mechanism of the synergistic effect between oversulfated chondroitin–6–sulfate and lysine or 6–aminohexanoic acid in enhancing the in–vitro activation of glutamic plasminogen by tissue plasminogen activator or urokinase. Blood Coagul Fibrinolysis 2010; 21:425–430. http://dx.doi.org/10.1097/MBC.0b013e328337b436spa
dc.relation.referencesWalter NG. Michaelis–Menten is dead, long live Michaelis–Menten!. Nat chem Biol 2006; 2:66–67. http://dx.doi.org/10.1038/nchembio0206-66spa
dc.relation.referencesCa-as O, Quijano A, Arbeláez LF. Activación y cinética comparativa de dos especies de Plasminógenos: Humano y Bovino. Bistua 2006; 4:3–12.spa
dc.relation.referencesCa-as O, Quijano A, Arbeláez LF. Cinética comparativa de la Plasmina canina con la humana, bovina y equina. Bistua 2007; 5:17–24.spa
dc.relation.referencesCa-as O, Quijano A, Arbeláez LF. Activación y Cinética comparativa de la Plasmina Bufalina con la humana. Rev Col Cien Pec 2010; 23:47–54.spa
dc.relation.referencesLongstaff C, Whitton CM. Aproposed reference method for plasminogen activators that enables calculation of enzyme activities in SI units. J Thromb Haemost 2004; 2:1416–1421. http://dx.doi.org/10.1111/j.1538-7836.2004.00816.xspa
dc.relation.referencesChakavarti B, Chakavarti D. Electrophoretic separation of proteins. J vis Exp 2008; 16:3791–758. http://dx.doi.org/10.3791/758spa
dc.relation.referencesOe T, Maekawa M, Satoh R, Lee SH, Goto T. Combining [13C6]–phenylisothiocyanate and the Edman degradation reaction: a possible breakthrough for absolute quantitative proteomics together with protein identification. Rapid commun mass spectrom 2010; 2:173–9. http://dx.doi.org/10.1002/rcm.4372spa
dc.relation.referencesChristensen B, Schack L, Kläning E, Sørensen ES. Osteopontin is cleaved at multiple sites close to its integrin–binding motifs in milk and is a novel substrate for plasmin and cathepsin D. J Biol Chem 2010; 285:7929–37. http://dx.doi.org/10.1074/jbc.M109.075010spa
dc.relation.referencesWeinberg ML, Felicori LF, Bello CA, Magalhaes HP, Almeida AP, Magalhaes A, Sanchez EF. Biochemical properties of a bushmaster snake venom serine proteinase (LV–Ka) and its kinin releasing activity evaluated in rat mesenteric arterial rings. J Pharmacol Sci 2004; 96:333–42 http://dx.doi.org/10.1254/jphs.FPJ04005Xspa
dc.relation.referencesDaviglus ML, Lloyd–jones DM, Pirzada A. Preventing cardiovascular disease in the 21st century: therapeutic and preventive implications of current evidence. Am J Cardiovasc Drugs 2006; 6:87–101. http://dx.doi.org/10.2165/00129784-200606020-00003spa
dc.relation.referencesWeisel JW. Fibrinogen and fibrin. Adv Protein Chem 2005; 70:247–99. http://dx.doi.org/10.1016/S0065-3233(05)70008-5spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.sourcehttps://revistamvz.unicordoba.edu.co/article/view/295spa
dc.subjectPlasminspa
dc.subjectGlu–Plasminogenspa
dc.subjectfibrinolysisspa
dc.subjecturokinasespa
dc.subjectkinetics.spa
dc.titleActivación y determinación de parámetros cinéticos de la Plasmina Humana y Ovis ariesspa
dc.title.translatedActivación y determinación de parámetros cinéticos de la Plasmina Humana y Ovis arieseng
dc.typeArtículo de revistaspa
dc.typeJournal articleeng
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.redcolhttp://purl.org/redcol/resource_type/ARTREFspa
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dspace.entity.typePublication
Archivos
Colecciones
HAJ. Revista MVZ